Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creatine Monohydrate (ALS-02) in Amyotrophic Lateral Sclerosis
NCT00069186Phase 3Unknown
- Sponsor
- Avicena Group
- Start
- Jun 2003
- Countries
- 1
01
Overview
A Phase 3 trial of creatine in amyotrophic lateral sclerosis (ALS), sponsored by Avicena Group. Status: unknown.
02
Drugs
creatine
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00069186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00069186.